News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
478,340 Results
Type
Article (33132)
Company Profile (401)
Press Release (444807)
Section
Business (135952)
Career Advice (680)
Deals (22761)
Drug Delivery (65)
Drug Development (71275)
Employer Resources (82)
FDA (11430)
Job Trends (10088)
News (239841)
Policy (19054)
Tag
Academia (2065)
Alliances (37381)
Alzheimer's disease (1047)
Antibody-drug conjugate (ADC) (88)
Approvals (11369)
Artificial intelligence (134)
Bankruptcy (185)
Best Places to Work (8781)
Biotechnology (315)
Breast cancer (198)
Cancer (1415)
Cardiovascular disease (98)
Career advice (599)
CAR-T (94)
Cell therapy (286)
Clinical research (56967)
Collaboration (444)
Compensation (194)
COVID-19 (1591)
C-suite (108)
Data (1283)
Diabetes (118)
Diagnostics (4834)
Earnings (50201)
Events (78987)
Executive appointments (324)
FDA (11987)
Funding (410)
Gene therapy (191)
GLP-1 (425)
Government (2435)
Healthcare (14010)
Infectious disease (1655)
Inflammatory bowel disease (114)
Interviews (101)
IPO (11598)
Job creations (1726)
Job search strategy (536)
Layoffs (306)
Legal (3217)
Lung cancer (206)
Lymphoma (94)
Manufacturing (154)
Medical device (8252)
Medtech (8255)
Mergers & acquisitions (11315)
Metabolic disorders (337)
Neuroscience (1339)
NextGen Class of 2024 (4278)
Non-profit (3326)
Northern California (1478)
Obesity (177)
Opinion (145)
Parkinson's disease (86)
Patents (90)
People (40382)
Phase I (18890)
Phase II (25547)
Phase III (18017)
Pipeline (483)
Postmarket research (1757)
Preclinical (7990)
Radiopharmaceuticals (252)
Rare diseases (247)
Real estate (3242)
Regulatory (14539)
Research institute (2046)
Southern California (1276)
Startups (2799)
United States (12941)
Vaccines (320)
Weight loss (112)
Date
Last 7 days (618)
Last 30 days (2157)
Last 365 days (31227)
2024 (30529)
2023 (34657)
2022 (43812)
2021 (45637)
2020 (41009)
2019 (32668)
2018 (24163)
2017 (24609)
2016 (22705)
2015 (26388)
2014 (19744)
2013 (15817)
2012 (16425)
2011 (16472)
2010 (15326)
Location
Africa (375)
Arizona (98)
Asia (28619)
Australia (5021)
California (3335)
Canada (1121)
China (272)
Colorado (128)
Connecticut (159)
Europe (64000)
Florida (455)
Georgia (96)
Illinois (280)
Indiana (171)
Maryland (531)
Massachusetts (2689)
Michigan (119)
Minnesota (181)
New Jersey (907)
New York (957)
North Carolina (699)
Northern California (1478)
Ohio (119)
Pennsylvania (785)
South America (531)
Southern California (1276)
Texas (469)
Washington State (352)
478,340 Results for "advanced cancer therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eisbach Bio Secures CPRIT Grant to Advance Novel Cancer Therapeutic
November 26, 2024
·
3 min read
Press Releases
Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics
November 6, 2024
·
2 min read
Press Releases
TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline
December 3, 2024
·
4 min read
Press Releases
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
December 12, 2024
·
10 min read
Press Releases
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
November 12, 2024
·
5 min read
Drug Development
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
Allarity Therapeutics, Inc. today announced that multiple patients in its Phase 2 clinical trial of stenoparib for advanced recurrent ovarian cancer have been on treatment for more than 30 weeks.
June 25, 2024
·
10 min read
Press Releases
Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
November 26, 2024
·
3 min read
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.
December 6, 2024
·
2 min read
·
Tristan Manalac
Startups
Halda Therapeutics Raises $126M in Series B Extension to Advance Two Cancer Candidates
The Connecticut-based biotech, which emerged from stealth last year, has secured $202 million to date as it looks to move two assets targeting prostate and breast cancer into the clinic.
August 12, 2024
·
2 min read
·
Tyler Patchen
Drug Development
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
Tizona Therapeutics, Inc. announced first-in-human Phase 1b clinical data of TTX-080, a novel, first-in-class, antibody targeting HLA-G, in patients with metastatic colorectal cancer and locally advanced/metastatic head and neck squamous cell carcinoma.
May 23, 2024
·
5 min read
1 of 47,834
Next
